United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - trimethoprim - oral tablet - 200mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - trimethoprim - oral tablet - 100mg

United States - English - NLM (National Library of Medicine)

redpharm drug, inc. - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x), sulfamethoxazole (unii: je42381tnv) (sulfamethoxazole - unii:je42381tnv) - trimethoprim 160 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim tablets, usp and other antibacterial drugs, sulfamethoxazole and trimethoprim tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. urinary tract infections: for the treatment of urinary tract infections due to susceptible strains of the following organisms: escherichia coli, klebsiella species, enterobacter species, morganella morganii, proteus mirabilis and proteus vulgaris. it is recommended that initial episodes of uncomplicated urinary tract infections be treated with a single effective antibacterial agent rather than the combination. acute oti

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - trimethoprim sulfate (unii: e377mf8eq8) (trimethoprim - unii:an164j8y0x), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - trimethoprim sulfate and polymyxin b sulfate ophthalmic solution is indicated in the treatment of surface ocular bacterial infections, including acute bacterial conjunctivitis, and blepharoconjunctivitis, caused by susceptible strains of the following microorganisms: staphylococcus aureus, staphylococcus epidermidis, streptococcus pneumoniae, streptococcus viridans, haemophilus influenza and pseudomonas aeruginosa. * *efficacy for this organism in this organ system was studied in fewer than 10 infections. trimethoprim sulfate and polymyxin b sulfate ophthalmic solution is contraindicated in patients with known hypersensitivity to any of its components.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ceva animal health pty ltd - trimethoprim; sulfadiazine - oral powder, pre-mix - trimethoprim pyrimidine active 130.0 mg/g; sulfadiazine sulfanyl active 650.0 mg/g - antibiotic & related - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - antibiotics - oral, parenteral | airsacculitis | amoxycillin sensitive bacteria | anaerobic bacterial infection | avian mycoplasmas | clavulanic acid sensitive | coccidiosis | coryza | crd | dermatoses | diarrhoea | endometritis | enteritis | enzootic pneumonia | escherichia coli | european brood disease | gentamicin sensitive | hypermotility | infected wounds | infections | lactating | mastitis | protozoal infections | pyometra | salmonellosis | sinusitis | systemic bacterial infection

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ausrichter pty ltd - glycine; lysine-l; methionine-dl; hyoscine methobromide; pectin; kaolin light; bismuth subcarbonate; calcium chloride; potassium chloride; magnesium sulfate; sodium acetate; trimethoprim; sulfadiazine; vitamin b2 = riboflavin; vitamin b1 hydrochloride = thiamine hydrochloride - oral tablet - glycine amino acid-glycine active 25.0 mg/100ml; lysine-l amino acid-lysine-l active 12.0 mg/100ml; methionine-dl amino acid-methionine-dl active 20.0 mg/100ml; hyoscine methobromide alkaloid active 10.0 mg/100ml; pectin carbohydrate active 1.38 g/100ml; kaolin light clay active 11.3 g/100ml; bismuth subcarbonate mineral-bismuth active 770.0 mg/100ml; calcium chloride mineral-calcium-salt active 15.0 mg/100ml; potassium chloride mineral-potassium active 20.0 mg/100ml; magnesium sulfate mineral-magnesium active 20.0 mg/100ml; sodium acetate mineral-sodium-salt active 25.0 mg/100ml; trimethoprim pyrimidine active 200.0 mg/100ml; sulfadiazine sulfanyl active 1.0 g/100ml; vitamin b2 = riboflavin vitamin-b2 active 20.0 mg/100ml; vitamin b1 hydrochloride = thiamine hydrochloride vitamin-b1 active 20.0 mg/100ml - alimentary system - calf | cattle | dog | horse | horse foal | beef | beef calf | bitch | bos indicus | bos taurus | bovine | buffalo | bull | bullo - organisms sensitive to sulphadiazine | organisms sensitive to trimethoprim

Canada - English - Health Canada

aa pharma inc - trimethoprim - tablet - 100mg - trimethoprim 100mg - urinary anti-infectives

Canada - English - Health Canada

aa pharma inc - trimethoprim - tablet - 200mg - trimethoprim 200mg - urinary anti-infectives

United States - English - NLM (National Library of Medicine)

golden state medical supply, inc. - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of trimethoprim tablets, usp and other antibacterial drugs, trimethoprim tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. for the treatment of initial episodes of uncomplicated urinary tract infections due to susceptible strains of the following organisms: escherichia coli , proteus mirabilis , klebsiella pneumoniae , enterobacter species, and coagulase-negative staphylococcus species, including s. saprophyticus . cultures and susceptibility tests should be performed to determine the susceptibility of

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen pharma ltd - trimethoprim - oral tablet - 100mg